Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Carvone helps treat skin issues by reducing melanin and stopping harmful cell growth.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Finasteride may cause kidney damage.

Inhibiting class I HDACs helps maintain hair growth ability in skin cells.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Lowering testosterone speeds up wound healing in male mice.

Certain mice without specific receptors or mast cells don't lose hair from stress.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.